Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
Conditions: Gender Dysphoria; Hormone Therapy Induced Morphologic Change Interventions: Drug: gender-affirming hormone therapy Sponsors: Medical University of Vienna Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Heart | Hormonal Therapy | Hormones | Liver | Pancreas | Research | Urology & Nephrology